{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:33:19Z","timestamp":1707525199282},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,6]]},"DOI":"10.7759\/cureus.44770","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T11:24:23Z","timestamp":1693999463000},"source":"Crossref","is-referenced-by-count":0,"title":["Stress-Dose Steroids: A Potential Therapeutic Option for Refractory Hyperkalemia"],"prefix":"10.7759","author":[{"given":"Pooya","family":"Zardoost","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeryab","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelsey","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry L","family":"Wehrum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.84a.17056","article-title":"Diagnosis and treatment of hyperkalemia","volume":"84","author":"Palmer BF","year":"2017","unstructured":"Palmer BF, Clegg DJ. Diagnosis and treatment of hyperkalemia. Cleve Clin J Med. 2017, 84:934-42. 10.3949\/ccjm.84a.17056","journal-title":"Cleve Clin J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/0885066605278969","article-title":"Hyperkalemia: a review","volume":"20","author":"Evans KJ","year":"2005","unstructured":"Evans KJ, Greenberg A. Hyperkalemia: a review. J Intensive Care Med. 2005, 20:272-90. 10.1177\/0885066605278969","journal-title":"J Intensive Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016121344","article-title":"How dangerous is hyperkalemia?","volume":"28","author":"Montford JR","year":"2017","unstructured":"Montford JR, Linas S. How dangerous is hyperkalemia?. J Am Soc Nephrol. 2017, 28:3155-65. 10.1681\/ASN.2016121344","journal-title":"J Am Soc Nephrol"},{"key":"ref4","unstructured":"Johns Hopkins Guides. Hypoaldosteronism. (2023). Accessed. May 15, 2023: https:\/\/www.hopkinsguides.com\/hopkins\/view\/Johns_Hopkins_Diabetes_Guide\/547067\/all\/Hypoaldosteronism.."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-008-0593-3","article-title":"Regulation of potassium (K) handling in the renal collecting duct","volume":"458","author":"Wang WH","year":"2009","unstructured":"Wang WH, Giebisch G. Regulation of potassium (K) handling in the renal collecting duct. Pflugers Arch. 2009, 458:157-68. 10.1007\/s00424-008-0593-3","journal-title":"Pflugers Arch"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung CL","year":"2008","unstructured":"Sprung CL, Annane D, Keh D, et al.. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008, 358:111-24. 10.1056\/NEJMoa071366","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane D","year":"2002","unstructured":"Annane D, S\u00e9bille V, Charpentier C, et al.. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002, 288:862-71. 10.1001\/jama.288.7.862","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002737","article-title":"Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017","volume":"45","author":"Annane D","year":"2017","unstructured":"Annane D, Pastores SM, Rochwerg B, et al.. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Crit Care Med. 2017, 45:2078-88. 10.1097\/CCM.0000000000002737","journal-title":"Crit Care Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710303371807","article-title":"Corticosteroid therapy in severe illness","volume":"337","author":"Lamberts SW","year":"1997","unstructured":"Lamberts SW, Bruining HA, de Jong FH. Corticosteroid therapy in severe illness. N Engl J Med. 1997, 337:1285-92. 10.1056\/NEJM199710303371807","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu D","year":"2013","unstructured":"Liu D, Ahmet A, Ward L, et al.. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013, 9:30. 10.1186\/1710-1492-9-30","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1992.421","article-title":"When is cortisol a mineralocorticoid?","volume":"42","author":"Clore J","year":"1992","unstructured":"Clore J, Schoolwerth A, Watlington CO. When is cortisol a mineralocorticoid?. Kidney Int. 1992, 42:1297-308. 10.1038\/ki.1992.421","journal-title":"Kidney Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2022.04.024","article-title":"Lactated Ringer's solution and risk of hyperkalemia in patients with reduced kidney function","volume":"364","author":"Rajasekaran A","year":"2022","unstructured":"Rajasekaran A, Bade N, Cutter GR, Rizk DV, Zarjou A. Lactated Ringer's solution and risk of hyperkalemia in patients with reduced kidney function. Am J Med Sci. 2022, 364:433-43. 10.1016\/j.amjms.2022.04.024","journal-title":"Am J Med Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/181129-stress-dose-steroids-a-potential-therapeutic-option-for-refractory-hyperkalemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:02Z","timestamp":1707509102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/181129-stress-dose-steroids-a-potential-therapeutic-option-for-refractory-hyperkalemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.44770","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,6]]}}}